Evidence map›Paper›PMID 28494957›Full record

ArticleBiophysical journal2017

Antioxidant and Membrane Binding Properties of Serotonin Protect Lipids from Oxidation.

Slim Azouzi, Hubert Santuz, Sandrine Morandat, Catia Pereira, Francine Côté, Olivier Hermine, Karim El Kirat, Yves Colin, Caroline Le Van Kim, Catherine Etchebest and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Serotonin Signaling through Lipid Membranes.ACS chemical neuroscience · 2024
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Tryptophan Metabolism Acts as a New Anti-Ferroptotic Pathway to Mediate Tumor Growth.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Slim AzouziUniversité Sorbonne Paris Cité, Université Paris Diderot, INSERM, Unité Biologie Intégrée du Globule Rouge UMR-S1134, Institut National de la Transfusion Sanguine, Laboratoire d'Excellence GR-Ex, Paris, France.
Hubert SantuzUniversité Sorbonne Paris Cité, Université Paris Diderot, INSERM, Unité Biologie Intégrée du Globule Rouge UMR-S1134, Institut National de la Transfusion Sanguine, Laboratoire d'Excellence GR-Ex, Paris, France.
Sandrine MorandatSorbonne Universités, Université de Technologie de Compiègne, CNRS, Laboratoire de Génie Enzymatique et Cellulaire FRE 3580, Centre de Recherche Royallieu, Compiègne, France.
Catia PereiraUniversité Sorbonne Paris Cité, Université Paris Diderot, INSERM, Unité Biologie Intégrée du Globule Rouge UMR-S1134, Institut National de la Transfusion Sanguine, Laboratoire d'Excellence GR-Ex, Paris, France.
Francine CôtéUniversité Sorbonne Paris Cité, Université Paris Descartes, INSERM, CNRS, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications U1163, Institut Imagine, Laboratoire d'Excellence GR-Ex, Paris, France.
Olivier HermineUniversité Sorbonne Paris Cité, Université Paris Descartes, INSERM, CNRS, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications U1163, Institut Imagine, Laboratoire d'Excellence GR-Ex, Paris, France.
Karim El KiratSorbonne Universités, Université de Technologie de Compiègne, CNRS, Laboratoire de BioMécanique et BioIngénierie UMR 7338, Centre de Recherche Royallieu, Compiègne cedex, France.
Yves ColinUniversité Sorbonne Paris Cité, Université Paris Diderot, INSERM, Unité Biologie Intégrée du Globule Rouge UMR-S1134, Institut National de la Transfusion Sanguine, Laboratoire d'Excellence GR-Ex, Paris, France.
Caroline Le Van KimUniversité Sorbonne Paris Cité, Université Paris Diderot, INSERM, Unité Biologie Intégrée du Globule Rouge UMR-S1134, Institut National de la Transfusion Sanguine, Laboratoire d'Excellence GR-Ex, Paris, France.
Catherine EtchebestUniversité Sorbonne Paris Cité, Université Paris Diderot, INSERM, Unité Biologie Intégrée du Globule Rouge UMR-S1134, Institut National de la Transfusion Sanguine, Laboratoire d'Excellence GR-Ex, Paris, France. Electronic address: catherine.etchebest@inserm.fr.
Pascal AmireaultUniversité Sorbonne Paris Cité, Université Paris Diderot, INSERM, Unité Biologie Intégrée du Globule Rouge UMR-S1134, Institut National de la Transfusion Sanguine, Laboratoire d'Excellence GR-Ex, Paris, France; Université Sorbonne Paris Cité, Université Paris Descartes, INSERM, CNRS, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications U1163, Institut Imagine, Laboratoire d'Excellence GR-Ex, Paris, France. Electronic address: pamireault@ints.fr.
Inserm · FRDélégation Paris 5 · FRUniversité de Technologie de Compiègne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serotonin (5-hydroxytryptamine, 5-HT) is a well-known neurotransmitter that is involved in a growing number of functions in peripheral tissues. Recent studies have shown nonpharmacological functions of 5-HT linked to its chemical properties. Indeed, it was reported that 5-HT may, on the one hand, bind lipid membranes and, on the other hand, protect red blood cells through a mechanism independent of its specific receptors. To better understand these underevaluated properties of 5-HT, we combined biochemical, biophysical, and molecular dynamics simulations approaches to characterize, at the molecular level, the antioxidant capacity of 5-HT and its interaction with lipid membranes. To do so, 5-HT was added to red blood cells and lipid membranes bearing different degrees of unsaturation. Our results demonstrate that 5-HT acts as a potent antioxidant and binds with a superior affinity to lipids with unsaturation on both alkyl chains. We show that 5-HT locates at the hydrophobic-hydrophilic interface, below the glycerol group. This interfacial location is stabilized by hydrogen bonds between the 5-HT hydroxyl group and lipid headgroups and allows 5-HT to intercept reactive oxygen species, preventing membrane oxidation. Experimental and molecular dynamics simulations using membrane enriched with oxidized lipids converge to further reveal that 5-HT contributes to the termination of lipid peroxidation by direct interaction with active groups of these lipids and could also contribute to limit the production of new radicals. Taken together, our results identify 5-HT as a potent inhibitor of lipid peroxidation and offer a different perspective on the role of this pleiotropic molecule.

Indexed as

AntioxidantsCell MembraneErythrocytesFlow CytometryHumansHydrogen BondingHydrophobic and Hydrophilic InteractionsLipid BilayersLipid PeroxidationLiposomesMembrane LipidsMicroscopy, ConfocalMolecular Dynamics SimulationOxidation-ReductionSerotoninAntioxidantsLipid BilayersLiposomesMembrane LipidsSerotonin

Identifiers

PMID28494957
PMCPMC5425403
OpenAlexW2612159699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.